Request for Information (RFI): Pharmacy Benefit Manager Compensation and Data Collection
Abstract
This request for information (RFI) solicits technical input on the services and business practices of pharmacy benefit managers ("PBMs") and their affiliates to inform implementation of recent legislation. It specifically focuses on gathering information to inform two specific legislative requirements that are effective beginning calendar year 2028: restrictions on the remuneration that PBMs and their affiliates may receive for services in connection with the utilization of covered Part D drugs; and data reporting requirements.
Federal Register Source
This document is published by the Office of the Federal Register, National Archives and Records Administration. Access the full regulatory text, preamble, and docket comments below.
View Full Text on FederalRegister.gov →Opens in new tab · federalregister.gov
Other Rules from HHS
Frequently Asked Questions
What is the 2026-12344 Federal Register document?
Document 2026-12344 is a Proposed Rule published by the Department of Health and Human Services in the Federal Register on June 18, 2026. This request for information (RFI) solicits technical input on the services and business practices of pharmacy benefit managers ("PBMs") and their affiliates to inform implementation of recent legislation. It specifically focuses on gathering information to inform two specific legislative requirements that are effective beginning calendar year 2028: restrictions on the remuneration that PBMs and their affiliates may receive for services in connection with the utilization of covered Part D drugs; and data reporting requirements. View the original at https://www.federalregister.gov/documents/2026/06/18/2026-12344/request-for-information-rfi-pharmacy-benefit-manager-compensation-and-data-collection.
Is document 2026-12344 an economically significant rule?
No. Document 2026-12344 is not classified as economically significant under Executive Order 12866. Economically significant rules require OIRA review and are estimated to have impacts of $100 million or more per year.